OBJECTIVE: The present study aimed to determine indirect costs of rheumatoid arthritis (RA) in a sample of patients followed at a public health-care facility in Brazil. Factors potentially associated with higher indirect costs in these patients were also investigated. METHODS: This cross-sectional study included patients between 18 and 65 years old with RA according to the American College of Rheumatology criteria. Patients who were working, on sick leave or retired early due to RA were invited to participate in the survey. A systematic structured interview was conducted in all patients including demographic, socioeconomic, and clinical variables and an experienced rheumatologist examined all patients. Estimates of the indirect costs in the preceding 12 months were performed using the human-capital approach based on the society perspective. Multiple linear regression models were used to determine the variables associated with higher indirect costs. RESULTS: A total of 192 patients were included in the study. Forty-seven of them (24.5%) had retired early due to RA, 62 others (32.3%) were on sick leave due to RA while 83 patients (43.2%) were working at the time of the interview. Estimated indirect cost for this population was US$ 466,107.81 or US$ 2,423.51 per patient per year. Factors associated with higher costs were RA poor functional class, high socioeconomic status and male patients (p < 0.001). CONCLUSIONS: Estimated costs found in our population are similar to that described in more developed countries. Indirect costs were higher in patients with poor functional classes, high socioeconomic status, and men.
OBJECTIVE: The present study aimed to determine indirect costs of rheumatoid arthritis (RA) in a sample of patients followed at a public health-care facility in Brazil. Factors potentially associated with higher indirect costs in these patients were also investigated. METHODS: This cross-sectional study included patients between 18 and 65 years old with RA according to the American College of Rheumatology criteria. Patients who were working, on sick leave or retired early due to RA were invited to participate in the survey. A systematic structured interview was conducted in all patients including demographic, socioeconomic, and clinical variables and an experienced rheumatologist examined all patients. Estimates of the indirect costs in the preceding 12 months were performed using the human-capital approach based on the society perspective. Multiple linear regression models were used to determine the variables associated with higher indirect costs. RESULTS: A total of 192 patients were included in the study. Forty-seven of them (24.5%) had retired early due to RA, 62 others (32.3%) were on sick leave due to RA while 83 patients (43.2%) were working at the time of the interview. Estimated indirect cost for this population was US$ 466,107.81 or US$ 2,423.51 per patient per year. Factors associated with higher costs were RA poor functional class, high socioeconomic status and male patients (p < 0.001). CONCLUSIONS: Estimated costs found in our population are similar to that described in more developed countries. Indirect costs were higher in patients with poor functional classes, high socioeconomic status, and men.
Authors: Erika Catay; Cecilia Castel Del Cid; Lorena Narváez; Edson J Velozo; Javier E Rosa; Luis J Catoggio; Enrique R Soriano Journal: Clinicoecon Outcomes Res Date: 2012-08-23
Authors: Ana Paula Monteiro Gomides; Cleandro Pires de Albuquerque; Ana Beatriz Vargas Santos; Rodrigo Balbino Chaves Amorim; Manoel Barros Bértolo; Paulo Louzada Júnior; Isabela Araújo Santos; Rina Dalva Neubarth Giorgi; Nathalia de Carvalho Sacilotto; Sebastião Cezar Radominski; Fernanda Maria Borghi; Maria Fernanda B Resende Guimarães; Maria Raquel da Costa Pinto; Gustavo Gomes Resende; Karina Rossi Bonfiglioli; Henrique Carriço da Silva; Maria de Fátima Lobato da Cunha Sauma; Marcel Lobato Sauma; Júlia Brito de Medeiros; Ivânio Alves Pereira; Gláucio Ricardo Wernwer de Castro; Claiton Viegas Brenol; Ricardo Machado Xavier; Licia Maria Henrique da Mota; Geraldo da Rocha Castelar Pinheiro Journal: PLoS One Date: 2019-03-01 Impact factor: 3.240